Safety and Immunogenicity of the Dengue Virus Vaccine TV005 (TetraVax-DV TV005) in Healthy Adults, Adolescents, and Children in Dhaka, Bangladesh
Clinical trial NCT02678455 · COMPLETED
Trial details
- NCT number
- NCT02678455
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2017-08-10
- Enrollment
- 192
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.